Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - cephalexin as the sodium salt - parenteral liquid/solution/suspension - cephalexin as the sodium salt antibiotic active 180.0 mg/ml - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - corynebacterium spp. | escherichia coli (e. coli) | micrococcus spp. | moraxella spp. | pasteurella multocida | proteus spp. | staphylococci | streptococci | bacterial canker | fowl cholera | including b-lactamase producin

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

mavlab pty. ltd. - oxytetracycline hydrochloride - oral powder, pre-mix - oxytetracycline hydrochloride antibiotic active 10.0 g/kg - antibiotic & related - birds - ornamental | domestic birds | amazon parrot | aviary bird | budgerigar | cage birds | caged bird | canary | cockatiel | - actinomyces spp. | bacterial enteritis | bacterial infection | chlamydia spp. | chronic respiratory disease | mycoplasma spp. | protozoa | rickettsiae | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | post-weaning bacterial enterit | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

mcneil products ltd - cetirizine hydrochloride - oral capsule - 10mg

Australia - inglese - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - gabapentin -

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - dipyridamole; aspirin - modified-release capsule - 200mg ; 25mg

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

amgrow pty ltd - bifenthrin; n-methyl-2-pyrrolidone; liquid hydrocarbon (paraffin) - emulsifiable concentrate - bifenthrin pyrethroid active 100.0 g/l; n-methyl-2-pyrrolidone solvent other 50.0 g/l; liquid hydrocarbon (paraffin) solvent other 567.5 g/l - insecticide - ant track or nest pest control | banana | barley | canola | citrus | clover | commercial building/structure - external | domesti - african black beetle | ant | argentine stem weevil | banana rust thrip | banana weevil borer | bill bug | black or black house ant | blue oat or pea mite | brown pasture looper | carpophilus beetle | citrus leaf-eating weevil | coastal brown ant | cockroach | corn earworm | fig longicorn | flea | fly | funnel ant | lawn armyworm | longtailed mealy bug | meat ant | mosquito | native budworm or bollworm | paper nest wasp | pasture webworm | redlegged earth mite | sod webworm | spider | stinging ant | strawberry spider mite | subterranean termite | sugar ant | tick | tomato russet mite | two spotted mite | vegetable weevil | whitefly | adult mosquitoes | argentine ant | banana spider mite | banded sugar ant | billbug | cotton bollworm | ctenocephalides spp. | desiantha weevil (wa) | dihammus vastator | grass caterpillar | grass grub | ground fleas | heliothis | la plata weevil | large cockroach | lawn caterpillar | madeira ant | native bollworm | ochetellus glaber | papernest wasps | pharaoh ant | red legged ear

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

farmalinx pty ltd - atrazine - dry flowable - atrazine triazine active 900.0 g/kg - herbicide - broom millet - dryland | broom millet - irrigated | canola - tt only - post sowing, pre emer | canola(tt varieties only) - pre e - amaranth or amaranthus | annual grass weed - suppression | annual ryegrass | annual ryegrass - suppression | barley grass | barley grass - suppression | barnyard or water grass | billygoat weed or blue top | black bindweed | blackberry nightshade | bladder ketmia | broadleaf weeds | broadleaf weeds - see label | broadleaf weeds and grasses | brome grass | brome grass - suppression | budda or butter pea | burr | caltrop or yellow vine | capeweed | charlock | clover | cobbler's pegs | common sida | common thornapple | corn gromwell, ironweed or sheepweed | crowsfoot grass | dock | dwarf marigold | fat hen | feathertop rhodes grass | flannel weed - sida cordifolia | fleabane | fumitory | geranium | giant or black pigweed | giant sensitive plant | ground or annual ground cherry | ivy leaf speedwell | london rocket | loosestrife | lovegrass | medic | mexican or prickly poppy | mintweed | mouse-ear chickweed | mustard | paddy melon | parthenium weed | paterson's curse | pigeon grass | pigweed spp. | plains grass |

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

international animal health products pty ltd - tylosin as the phosphate - oral powder, pre-mix - tylosin as the phosphate antibiotic active 250.0 g/kg - antibiotic & related - cattle - beef | pigs | boar | bovine | bullocks | bulls | calves | cows | feedlot cattle | gilt | growers | heifer speyed | heif - antibiotic - anti-infective | feed additive | ileitis | liver abscess | swine dysentery | abrasions | abscesses | airsacculitis | antiseptic | avian mycoplasmas | blackhead | body odours | bowed tendons | broad spectrum | burns | coccidiosis | coliform complex | conjunctivitis | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | endometritis | enteric diseases | enzootic pneumonia | feed efficiency | fungal infections | girth galls | infections | inflammed pads | itching | keratolytic | lacerations | mastitis | mycoplasmas | odours | open wounds | otitis | pruritis | queensland itch | respiratory disease | saddle rash | salmonellosis | scabs | scaly skin | sheath rot | skin irritations | sores | swine dysentery | teat cracking | teat infections | topical infections | udder sores | weight gain | wire cuts | wounds

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

international animal health products pty ltd - bifidobacterium bifidum; enterococcus faecium; lactobacillus delbrueckii subspecies bulgaricus; lactobacillus acidophilus; lactobacillus plantarum; lactobacillus rhamnosus; streptococcus salivarius subspecies thermophilus - oral powder, pre-mix - bifidobacterium bifidum biological-organism active 180.0 m cfu/g; enterococcus faecium biological-organism active 180.0 m cfu/g; lactobacillus delbrueckii subspecies bulgaricus biological-organism active 180.0 m cfu/g; lactobacillus acidophilus biological-organism active 180.0 m cfu/g; lactobacillus plantarum biological-organism active 180.0 m cfu/g; lactobacillus rhamnosus biological-organism active 180.0 m cfu/g; streptococcus salivarius subspecies thermophilus biological-organism active 180.0 m cfu/g - nutrition & metabolism - animal | birds | cage birds | calf | cat | cattle | dog | dog - puppy | goat | goat kid | horse | horse foal | kitten | lamb | p - establishment of gut microflora | intestinal dysfunction | productivity improvements | promote animal growth | reduced mortality | re-establishment of gut microflora | feed conversion | finishing | following antibiotic use | growth promotion | growth rate | improving feed efficiency | increasing rate of weight gain | liveweight gain | post-antibiotic therapy

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

bayer new zealand limited - interferon beta-1b 0.25mg (20% excess in quantity filled) - injection with diluent - 8 miu - active: interferon beta-1b 0.25mg (20% excess in quantity filled) excipient: albumin hydrochloric acid mannitol sodium hydroxide hydrochloric acid sodium chloride water for injection - betaferon is indicated for: · the treatment of patients with a single clinical event suggestive of multiple sclerosis and at least two clinically silent magnetic resonance imaging (mri) lesions characteristic of multiple sclerosis, if alternative diagnoses have been excluded, · the treatment of ambulatory patients, with relapsing-remitting multiple sclerosis characterised by at least two attacks of neurological dysfunction over a two year period followed by complete or incomplete recovery. · the reduction of frequency and severity of clinical relapses and for slowing the progression of disease in patients with secondary progressive multiple sclerosis